Back to search

United States· US:68998-228_2526b65f-4cd0-d493-e063-6294a90ab063

Allergy Multi Symptom

A medicinal product containing chlorpheniramine maleate; phenylephrine hydrochloride; acetaminophen, registered in United States by MARC GLASSMAN, INC..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedAllergy Multi SymptomATC—REGISTER NO.US:68998-228_2526b65f…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN
Manufacturer
MARC GLASSMAN, INC.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    68998-228-02
  • ndc11
    6899822802
    2 BLISTER PACK in 1 CARTON (68998-228-02) / 12 TABLET, COATED in 1 BLISTER PACK

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlorpheniramine maleate; phenylephrine hydrochloride; acetaminophen in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorpheniramine maleate; phenylephrine hydrochloride; acetaminophen products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Bulgaria · Тайлолфен Хот
  • Spain · Abacat, Anticatarral Edigen
  • Malta · Flucontrol Max
  • Poland · Flucontrol Hot, Flucontrol Max
  • Portugal · Gripalgin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b272fa6b-b8f8-49ab-b1c3-b22a87bdb9ce
GET /v1/drugs/b272fa6b-b8f8-49ab-b1c3-b22a87bdb9ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2; 5; 325",
  "substance": "CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN",
  "productndc": "68998-228",
  "dosage_form": "TABLET, COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1; mg/1",
  "application_number": "M012",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about chlorpheniramine maleate; phenylephrine hydrochloride; acetaminophen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.